Tom McKillop
Tom McKillop
Sir Thomas Fulton Wilson "Tom" McKillop, FRSis a Scottish chemist, who was CEO of AstraZeneca PLC from 1999 until 2006 and chairman of the RBS Group from 2006 until 2008...
bigger engage major none reason strategic
We have no strategic need to be bigger -- none at all. So there is no reason to engage in major M&A activity.
devices history partly period realistic review reviews tend
The history of this division, partly because of the devices element, is that reviews and approvals tend to be very slow, so we made realistic to conservative assumptions on what the review period should be.